Operations

Jasmine Percivall

Commercialisation Manager
Image
Profile Placeholder Image

Biography

Contact details:

Jasmine.Percival@earlham.ac.uk

Jasmine is the Commercialisation Manager in the Business Development and Impact team, supporting the delivery of knowledge exchange, commercialisation, and impact strategies.

Her role includes identifying and developing opportunities for commercialisation of EI’s research, building external partnerships, raising awareness of the institute’s capabilities, and supporting the development and management of Institute's IP portfolio.

Before joining the institute, Jasmine trained and qualified as a UK and European Patent Attorney. She has worked with universities, research institutes, start-ups and multinational companies, advising on the protection and commercialisation of biotechnology innovations. Her experience includes drafting and prosecuting patent applications, supporting licensing and collaboration activities, and developing IP strategies that align scientific innovation with commercial objectives.

Prior to this, Jasmine completed her PhD at the Quadram Institute, where her research focused on the metabolism of anthocyanins by the human gut microbiota, using a combination of microbiological, molecular biology and analytical techniques.

Jasmine is passionate about translating scientific breakthroughs into real-world applications to deliver meaningful impact.

Postdoctoral Research Scientist (Plant Engineering Biology)

Salary range:
Post no.
Contract length:
Department:
Opening date: 27 March 2026
Closing date: 23 April 2026

Apply for this job

You will need to download, save and complete a copy of the application form using Microsoft Word or prepare a copy of your CV that contains all the information requested in the application form.

Apply

Applications are invited for a Postdoctoral Research Scientist to join the Laboratory of Dr Sarah Guiziou, and more generally the engineering biology consortium of the Earlham Institute, based in Norwich, UK. This position is funded by Dr Sarah Guiziou’s UKRI Future Leader Fellowship

Research

Kirsty Culley

Research Programme Manager
Image
Profile photo of Kirsty Culley

Biography

Contact details:

  • +44 1603 450 450

kirsty.culley@earlham.ac.uk

ORCiD

LinkedIn

Kirsty joined the Earlham Institute in February 2026 as the Research Programme Manager for the Cellular Genomics Institute Strategic Programme (ISP). She leads the coordination and delivery of the programme, which focuses on genomic and transcriptomic heterogeneity in plant and animal systems, using advanced single-cell and spatial genomics technologies. She works closely with programme leadership and a wide range of internal and external stakeholders to ensure successful delivery and alignment with the Institute’s research strategy.

Kirsty is an experienced science collaboration and programme management professional with a strong track record of delivering complex, multi-stakeholder scientific initiatives. Previously, she served as Science Collaboration Manager at Anglia Innovation Partnership, Norwich Research Park, developing and delivering programmes linking academia, industry, and funders. Her work supported successful partnerships and funding opportunities, strengthening engagement across research, industry, and innovation communities.

Kirsty obtained her Bachelor’s degree in Biological Science and PhD in Molecular Biology from the University of East Anglia, UK. She continued her research career at the Hospital for Special Surgery in New York, focusing on molecular pathways underlying the initiation and progression of arthritis, as well as directing the Resident Research Programme, which formed multidisciplinary teams and strengthened links between research and surgical departments.

Special Feature Science
March 19, 2026

Seven ways Earlham Institute’s research improves future health

New study maps cellular mechanisms driving fibrosis in Crohn's Disease

16 March 2026

Researchers at the Earlham Institute, the University of Edinburgh and Heriot-Watt University have analysed gut cells to understand the drivers behind fibrosis (scarring), a common complication in Crohn’s Disease affecting 10-20% of patients.

Notes to editors.